OraSure has partnered with Molecular Testing Labs to offer a test that measures concentrations of tenofovir-diphosphate from a fingerstick dried blood spot sample. TFV-DP concentrations in DBS samples characterize cumulative exposure over the past several weeks. The DBS test can be collected at home by the patient, or in-clinic by a provider. After the sample is collected, it is shipped to a CAP accredited, CLIA licensed laboratory for processing, and within a few days, the provider receives the test result and interpretation, via a secure portal. TFV-DP test results should be used in conjunction with all other available clinical information to support PrEP or ART regimens.
The urine Point of Care test is currently available for research use. This test will allow providers to test patients urine, and see the adherence results within a few minutes of their visit.
*OraSure provides information regarding reimbursement (including, in some instances, potentially applicable CPT, HCPCS and/or analogous state or local codes or designations) for background purposes only. It does not constitute legal advice or a recommendation regarding clinical practice. Information provided is gathered from third-party sources and is subject to change without notice. The provider has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided. Any decision regarding specific coding is at the discretion of the healthcare professional, and provision of this information does not guarantee or facilitate reimbursement. OraSure makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other payers as to the correct form of billing or the amount that will be paid to providers of service. Please contact your Medicare contractor, insurance provider, other payers, reimbursement specialists and/or legal counsel for interpretation of coding, coverage and payment policies or specific billing questions or concerns. Nothing herein is intended to promote or facilitate the purchase or use of products outside of their approved or cleared indications, and appropriate use of products should be based on the healthcare professional’s medical judgment.